Clinical supply models need to provide for an adequate supply of patient kits that allow for variations in patient recruitment levels and clinical site activity. Traditional, or supply-led models, address this challenge by creating large quantities of finished patient kits up front in order to create a cushion of static inventory to manage uneven demand. However, this cushion comes at a cost.
Ensuring an adequate, timely, and quality supply of comparator product for clinical trials is critical, but clinical trial sponsors face several challenges in this endeavor. Delivery delays or under-projection of needed quantities could have a negative impact on timelines, budgets, and patients relying on new treatment options for unmet needs. In this article, learn seven strategies to help you avoid clinical supply delays.
Accurate and timely delivery of clinical trial supplies helps to ensure that a study’s timeline stays on track. Sponsors often focus on up front planning to ensure sites are prepared to reach clinical milestones but ignore the logistical challenges of reconciling and destroying clinical returns. This article breaks down how to effectively manage the clinical supply returns process and how to design a more holistic strategy.
Free trade zones offer many advantages for customers interested in clinical trial supply. The zone provides fast, safe, and secure transit to a controlled storage situation, which can delay or eliminate custom duties. Learn more about how free trade zones can offer cost-efficient ways to manage your clinical trial.